However, majority of studies which report detection of BIRC5 in dog cancers such as CMT53, nasal carcinoma54, cutaneous squamous cell carcinomas55, canine cutaneous sebaceous tumour56, canine osteosarcomas57, canine mast cell tumours58 etc. are based on immunohistochemistry analysis using specific antibodies. This evidence concerns the gene BIRC5 and cancer.